Intramural anteroseptal substrate, incessant VT with exit close to His region, inducible after RCC 3 RF apps (50W, 90sec each), effective and safe PFA with Tactiflex Duo in RCC with low dose to avoid His damage and coronary spasm @PranavBhagirath@hospitalclinic@aportasanchez
Presented at #AHA25:
In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results: https://t.co/jM3DdE3mUS
@AHAScience
In a statewide registry from Washington State, revascularization volumes decreased. Clinical acuity and procedural complexity increased for PCI with an attendant increase in risk adjusted mortality. https://t.co/0vdgHV40af @AkashKataruka@Ravi_Hira_MD@UWMedHeart#AHAJournals
Collectively, more than 100 staff at Brigham & Women’s, Mass General Hospital, & Boston Medical Center test positive for #COVID19 https://t.co/mvFWs3uVhF
NEW: Monday 23 March update of our coronavirus mortality trajectories tracker
• UK is finally locking down, as its death tolls reaches 355
• US death curve continues to steepen, passing 500 with no national lockdown
Live version 🔥 FREE TO READ 🔥 here https://t.co/VcSZISFxzF